$
0.000
0(0.000%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
High
5.870
Open
5.720
VWAP
5.77
Vol
45.30K
Mkt Cap
216.93M
Low
5.570
Amount
261.27K
EV/EBITDA(TTM)
--
Total Shares
24.43M
EV
125.89M
EV/OCF(TTM)
--
P/S(TTM)
12.33
Profound Medical Corp. is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), AI-enhanced planning, robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
6.52M
+56.63%
-0.362
+81.25%
4.90M
+72.89%
-0.380
-0%
3.39M
+132.15%
-0.398
+41.96%
Estimates Revision
The market is revising Downward the revenue expectations for Profound Medical Corp. (PROF) for FY2025, with the revenue forecasts being adjusted by -4.65% over the past three months. During the same period, the stock price has changed by 23.68%.
Revenue Estimates for FY2025
Revise Downward
down Image
-4.65%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+32.07%
In Past 3 Month
Stock Price
Go Up
up Image
+23.68%
In Past 3 Month
3 Analyst Rating
up Image
101.42% Upside
Wall Street analysts forecast PROF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PROF is 11.36 USD with a low forecast of 11.03 USD and a high forecast of 12.03  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
up Image
101.42% Upside
Current: 5.640
sliders
Low
11.03
Averages
11.36
High
12.03
Raymond James
Michael Freeman
Strong Buy
to
Outperform
downgrade
$17 -> $11
2025-05-09
Reason
Lake Street
Benjamin Haynor
Strong Buy
Maintains
$17 → $11
2025-04-23
Reason

Valuation Metrics

The current forward P/E ratio for Profound Medical Corp (PROF.O) is -3.80, compared to its 5-year average forward P/E of -9.26. For a more detailed relative valuation and DCF analysis to assess Profound Medical Corp 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-9.26
Current PE
-3.80
Overvalued PE
-4.53
Undervalued PE
-14.00

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-8.54
Current EV/EBITDA
-2.93
Overvalued EV/EBITDA
-3.49
Undervalued EV/EBITDA
-13.60

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
19.27
Current PS
7.63
Overvalued PS
29.33
Undervalued PS
9.20

Financials

Annual
Quarterly
FY2025Q1
YoY :
+82.14%
2.62M
Total Revenue
FY2025Q1
YoY :
+41.75%
-11.17M
Operating Profit
FY2025Q1
YoY :
+62.85%
-10.72M
Net Income after Tax
FY2025Q1
YoY :
+33.33%
-0.36
EPS - Diluted
FY2025Q1
N/A
Free Cash Flow
FY2025Q1
YoY :
+17.48%
70.70
Gross Profit Margin - %
FY2025Q1
N/A
FCF Margin - %
FY2025Q1
YoY :
-10.59%
-409.16
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
2
100.2K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

PROF News & Events

Events Timeline

2025-06-10 (ET)
2025-06-10
08:17:13
Profound Medical announces first commercial BPH treatment using TULSA-AI
select
2025-06-04 (ET)
2025-06-04
07:48:23
Profound Medical enters agreement with former NFL player Leonard Wheeler
select
2025-04-29 (ET)
2025-04-29
07:39:07
Profound Medical announces initial perioperative data from CAPTAIN trial
select
Sign Up For More Events

News

2.0
05-13Benzinga
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
2.0
05-09Benzinga
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
2.0
05-09Benzinga
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Sign Up For More News

FAQ

arrow icon

What is Profound Medical Corp (PROF) stock price today?

The current price of PROF is 5.64 USD — it has decreased -0.97 % in the last trading day.

arrow icon

What is Profound Medical Corp (PROF)'s business?

arrow icon

What is the price predicton of PROF Stock?

arrow icon

What is Profound Medical Corp (PROF)'s revenue for the last quarter?

arrow icon

What is Profound Medical Corp (PROF)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Profound Medical Corp (PROF)'s fundamentals?

arrow icon

How many employees does Profound Medical Corp (PROF). have?

arrow icon

What is Profound Medical Corp (PROF) market cap?